The Smartest Investors Club
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Smartest Investors Club

Investing

Agreement to Develop New Expandable Graphite Facility

by July 28, 2025
July 28, 2025
Agreement to Develop New Expandable Graphite Facility

International Graphite (IG6:AU) has announced Agreement to develop new Expandable Graphite facility

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
RAD receives IND approval from US FDA for Betabart (RV-01)
next post
Comet share sale and debt repayment

You may also like

Halcones Precious Metals Grants Stock Options and Restricted...

Tech 5: Meta Plans Multi-Billion AI Bet, Apple...

2025 Crypto Market: Q2 Review and Forecast

Trump and Vietnam Strike Tariff Deal, Last-Minute Agreement...

Sprott: Platinum Price Potentially at “Tipping Point” as...

Top 5 Canadian Mining Stocks This Week: Mkango...

Crypto Market Recap: Bitcoin Drops Below US$100K After...

Crypto Market Recap: Trump Media Files “Crypto Blue...

Osisko Metals Infill and Expansion Drilling Intersects New...

Seabed Mining Heats Up as Lockheed Martin Courts...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Homerun Resources Inc. Receives Joint Support Plan from BNDES and FINEP Indicating...

    • Galan Lithium Limited: Incentive Regime for HMW Project in Argentina

    • Anteros Metals Initiates Channel Sampling at Havens Steady Following Grant Confirmation and Exploration Permit Approval

    • Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility

    • Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart

    Categories

    • Business (70)
    • Investing (523)
    • Politics (700)
    • World (262)
    • Terms & Conditions
    • Privacy Policy
    • About us

    Disclaimer: thesmartestinvestorsclub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 thesmartestinvestorsclub.com | All Rights Reserved


    Back To Top